Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 18.81
(9.49%)
CNY 18.81
(9.49%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 389.93 Million CNY | 6.23% |
| 2022 | 367.05 Million CNY | 1.83% |
| 2021 | 360.46 Million CNY | -0.97% |
| 2020 | 364 Million CNY | 38.07% |
| 2019 | 263.63 Million CNY | 2.05% |
| 2018 | 258.34 Million CNY | 9.11% |
| 2017 | 236.77 Million CNY | 8.17% |
| 2016 | 218.9 Million CNY | 20.44% |
| 2015 | 181.74 Million CNY | 27.24% |
| 2014 | 142.83 Million CNY | 25.35% |
| 2013 | 113.94 Million CNY | -9.3% |
| 2012 | 125.62 Million CNY | 12.15% |
| 2011 | 112.01 Million CNY | 72.09% |
| 2010 | 65.09 Million CNY | 74.29% |
| 2009 | 37.34 Million CNY | 55.37% |
| 2008 | 24.03 Million CNY | 27.62% |
| 2007 | 18.83 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 392.76 Million CNY | 0.73% |
| 2024 Q3 | 390.21 Million CNY | -0.86% |
| 2024 Q2 | 393.58 Million CNY | 0.21% |
| 2023 Q1 | 402.26 Million CNY | 9.59% |
| 2023 FY | 389.93 Million CNY | 6.23% |
| 2023 Q2 | 403.94 Million CNY | 0.42% |
| 2023 Q3 | 386.34 Million CNY | -4.36% |
| 2023 Q4 | 389.93 Million CNY | 0.93% |
| 2022 Q2 | 354.17 Million CNY | -0.16% |
| 2022 Q4 | 367.05 Million CNY | 1.28% |
| 2022 FY | 367.05 Million CNY | 1.83% |
| 2022 Q3 | 362.41 Million CNY | 2.32% |
| 2022 Q1 | 354.75 Million CNY | -1.58% |
| 2021 Q4 | 360.46 Million CNY | 2.8% |
| 2021 Q1 | 378.16 Million CNY | 3.89% |
| 2021 FY | 360.46 Million CNY | -0.97% |
| 2021 Q2 | 366.97 Million CNY | -2.96% |
| 2021 Q3 | 350.63 Million CNY | -4.45% |
| 2020 Q1 | 277.66 Million CNY | 5.32% |
| 2020 Q2 | 324.41 Million CNY | 16.83% |
| 2020 FY | 364 Million CNY | 38.07% |
| 2020 Q4 | 364 Million CNY | 9.57% |
| 2020 Q3 | 332.2 Million CNY | 2.4% |
| 2019 Q2 | 259.07 Million CNY | -6.16% |
| 2019 Q1 | 276.08 Million CNY | 6.87% |
| 2019 FY | 263.63 Million CNY | 2.05% |
| 2019 Q4 | 263.63 Million CNY | 8.86% |
| 2019 Q3 | 242.18 Million CNY | -6.52% |
| 2018 Q1 | 235.18 Million CNY | -0.67% |
| 2018 Q4 | 258.34 Million CNY | 17.36% |
| 2018 Q3 | 220.12 Million CNY | -4.69% |
| 2018 FY | 258.34 Million CNY | 9.11% |
| 2018 Q2 | 230.95 Million CNY | -1.8% |
| 2017 Q3 | 220.85 Million CNY | -7.14% |
| 2017 Q2 | 237.83 Million CNY | -1.67% |
| 2017 Q1 | 241.87 Million CNY | 10.5% |
| 2017 FY | 236.77 Million CNY | 8.17% |
| 2017 Q4 | 236.77 Million CNY | 7.21% |
| 2016 Q1 | 186.81 Million CNY | 2.79% |
| 2016 Q2 | 189.12 Million CNY | 1.24% |
| 2016 Q3 | 182.78 Million CNY | -3.35% |
| 2016 Q4 | 218.9 Million CNY | 19.76% |
| 2016 FY | 218.9 Million CNY | 20.44% |
| 2015 Q4 | 181.74 Million CNY | 9.28% |
| 2015 Q2 | 192.12 Million CNY | 28.89% |
| 2015 Q1 | 149.06 Million CNY | 4.36% |
| 2015 FY | 181.74 Million CNY | 27.24% |
| 2015 Q3 | 166.31 Million CNY | -13.44% |
| 2014 Q1 | 132.43 Million CNY | 16.22% |
| 2014 FY | 142.83 Million CNY | 25.35% |
| 2014 Q2 | 132.87 Million CNY | 0.33% |
| 2014 Q4 | 142.83 Million CNY | 21.98% |
| 2014 Q3 | 117.09 Million CNY | -11.87% |
| 2013 Q2 | 118.39 Million CNY | 0.02% |
| 2013 Q3 | 118.14 Million CNY | -0.21% |
| 2013 Q1 | 118.37 Million CNY | -5.77% |
| 2013 Q4 | 113.94 Million CNY | -3.55% |
| 2013 FY | 113.94 Million CNY | -9.3% |
| 2012 Q1 | 120.4 Million CNY | 7.49% |
| 2012 Q2 | 116.95 Million CNY | -2.86% |
| 2012 Q3 | 124.55 Million CNY | 6.49% |
| 2012 FY | 125.62 Million CNY | 12.15% |
| 2012 Q4 | 125.62 Million CNY | 0.86% |
| 2011 Q3 | 92.34 Million CNY | 5.81% |
| 2011 Q1 | 65.71 Million CNY | 0.95% |
| 2011 Q2 | 87.27 Million CNY | 32.81% |
| 2011 Q4 | 112.01 Million CNY | 21.3% |
| 2011 FY | 112.01 Million CNY | 72.09% |
| 2010 Q2 | 40.44 Million CNY | 0.0% |
| 2010 FY | 65.09 Million CNY | 74.29% |
| 2010 Q4 | 65.09 Million CNY | 92.76% |
| 2010 Q3 | 33.76 Million CNY | -16.51% |
| 2009 FY | 37.34 Million CNY | 55.37% |
| 2009 Q4 | 37.34 Million CNY | 0.0% |
| 2008 FY | 24.03 Million CNY | 27.62% |
| 2007 FY | 18.83 Million CNY | 0.0% |